Document is current
Any future updates will be listed below
-
Authors
Wichmann, Dominic
Hoenigl, Martin
Koehler, Philipp
Koenig, Christina
Lund, Frederike
Mang, Sebastian
Strauß, Richard
Weigand, Markus A.
Hohmann, Christian
Kurzai, Oliver
Heußel, Claus
Kochanek, Matthias
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 22 May 2025
First Online: 4 June 2025
Declarations
:
: D.W. has received consulting honoraria from Gilead Science GmbH; lecture honoraria from Gilead Science GmbH, Shionogi, Eumedica Pharmaceuticals AG, Pfizer Pharma GmbH, InfectoPharm Arzneimittel und Consilium GmbH, 3 M, Mundipharma GmbH, AstraZeneca GmbH and MSD Sharp & Dohme GmbH and research support from Shionogi. M.H. has received lecture honoraria from StreamedUp! GmbH, Shionogi, Medentech Ltd., Volumen, Mundipharma GmbH, AstraZeneca GmbH and research support from F2G Ltd., Gilead Science GmbH, Pfizer Pharma GmbH, Pulmocide Ltd., Mundipharma GmbH, IMMY and Melinta Therapeutics. P.K. has received consulting honoraria from Ambu GmbH, Gilead Science GmbH, Infill Healthcare Communications gmbH, Mundipharma GmbH, NOXXON N.V. and Pfizer Pharma GmbH; lecture honoraria from Akademie für Infektionsmedizin, Ambu GmbH, Bio-Rad Laboratories Inc., Datamed SA, European Confederation of Medical Mycology, Gilead Science GmbH, GPR Academy Rüsselsheim, HELIOS Kliniken, Jazz Pharmaceuticals Germany GmbH, medupdate GmbH, MedMedia GmbH, Pfizer Pharma GmbH, Scilink Comunicación Científica S.C., StreamedUp! GmbH, Universitätsklinikum der LMU München and research support from Gilead Science GmbH. C.K. has received consulting honoraria from Gilead Science GmbH and lecture honoraria from Shionogi, Pfizer Pharma GmbH, Gilead Science GmbH.F.L. has received lecture honoraria from Gilead Science GmbH, Shionogi, MSD Sharp & Dohme GmbH and Pfizer Pharma GmbH.S.M. has nothing to declare. R.S. has received consulting honoraria from Gilead Science GmbH; lecture honoraria from Schöchl Medical Education e.U., Biotest AG, Pfizer Pharma GmbH, Amomed Pharma, InfectoPharm Arzneimittel und Consilium GmbH, Shionogi, Tillotts Pharma GmbH, Mundipharma GmbH, HELIOS Kliniken, Sana Kliniken, DGI– Akademie für Infektionsmedizin, BDI-Veranstaltungsservice, Forum für Medizinische Fortbildung and research support from Biotest AG.M.W. has received consulting honoraria from B. Braun SE, Gilead Science GmbH, Boehringer Ingelheim International GmbH, MSD Sharp & Dohme GmbH, Shionogi, Eumedica Pharmaceuticals AG, Beckman Coulter Inc., Biotest AG, Sedana Medical AB, Swedish Orphan Biovitrum GmbH and Mundipharma GmbH; lecture honoraria from Pfizer Pharma GmbH, MSD Sharp & Dohme GmbH, Mundipharma GmbH and Gilead Science GmbH and research support from Dr. Franz Köhler Chemie GmbH.Ch.H. has received lecture honoraria from Gilead Science GmbH.O.K. has received consulting honoraria from Berufsgenossenschaft Rohstoffe und chemische Industrie and Laboratoire National de Santé Luxembourg; lecture honoraria from Pfizer Pharma GmbH, Gilead Science GmbH and FUJIFILM Wako Chemicals Europe GmbH and research support from FUJIFILM Wako Chemicals Europe GmbH, Virotech Diagnostics GmbH, Pfizer Pharma GmbH, MSD Sharp & Dohme GmbH and Basilea Pharmaceutica Ltd. Cl.H. has received consulting honoraria from Boehringer Ingelheim International GmbH; lecture honoraria from AstraZeneca GmbH, Pfizer Pharma GmbH and Boehringer Ingelheim; research support from Exscientia and holds shares in GlaxoSmithKline GmbH & Co. KG.M.K. holds shares in BioNTech SE.
